Merck (MRK) Drugs Under Scanner Of Cholesterol Study

Merck (MRK) Drugs Under Scanner Of Cholesterol Study

Benzinga - 31 minutes ago
Merck & Co., Inc. (NYSE: MRK) is likely to be impacted by a new cholesterol study that has its multibillion cholesterol medications under the scanner. Analysts are flying down to Orlando, Fla ...